Here are the DEF 14A proxy statements from Intensity Therapeutics, Inc. (INTS) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow INTS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full INTS filings page.
Intensity Therapeutics, Inc. is asking stockholders to vote at its 2026 annual meeting, which will be held virtually via live audio webcast on June 16, 2026 at 10:30 a.m. Eastern Time. Holders of common stock at the close of business on April 23, 2026 may vote.
Stockholders are being asked to elect two directors for three-year terms ending in 2029, ratify the appointment of EisnerAmper LLP as independent registered public accounting firm for the year ending December 31, 2026, and approve amendments to two equity plans. The Company seeks to add 150,000 shares of common stock to the 2021 Stock Incentive Plan and 25,000 shares to the 2024 Employee Stock Purchase Plan.
The board also requests authority to postpone or adjourn the meeting if additional proxies are needed or a quorum is not present. The proxy statement describes voting methods, virtual meeting access and detailed information on board structure, executive compensation and ownership.